Reason for quinoloneNumber of patientsDays of therapy (median)1st and 3rd quartiles (days)
Multifactorial(ICU)9(27%)2219-49
Drug monoresistance/intolerance9(27%)8456-224
Deranged liver function7(21%)5656-87.5
MDRTB5(15%)252112-365
Renal disease2(6%)210.5N/A
Suspected MDRTB1(3%)21N/A